4/A

PRIMARY DOCUMENT

Company: PALVELLA THERAPEUTICS, INC.
Filed: June 25, 2020
Period of Report: June 23, 2020
Accession Number: 0001562180-20-004696

View Document ↗ View on SEC.gov ↗